lynch syndrome endometrial glutathione

lynch syndrome endometrial glutathione Hereditary Cancer: Syndrome, Mismatch Repair Deficiency, and Emerging Genetic Predispositions—A Comprehensive Review with Clinical and Laboratory Guidelines Lynch syndrome diagnostic testing pathways

Name: lynch syndrome endometrial glutathione Hereditary Cancer: Syndrome, Mismatch Repair Deficiency, and Emerging Genetic Predispositions—A Comprehensive Review with Clinical and Laboratory Guidelines Lynch syndrome diagnostic testing pathways
Brand: msw-creativ-solutions.de
SKU: 94151131237
Price: 20.85 USD
Availability: InStock
Rating: 4.6264 (25 reviews)

Lynch syndrome diagnostic testing pathways in endometrial cancers: a nationwide English registry based study Journal of Medical Genetics Metabolism pathway based subtyping in endometrial cancer: An integrated study by multi omics analysis and machine learning algorithms: Molecular Therapy Nucleic Acids Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer Scientific Reports Lynch Syndrome and Gynecologic Tumors Encyclopedia MDPI Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome ScienceDirect Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium Journal of Hematology & Oncology Springer Nature Link

SKU: 94151131237 · From msw-creativ-solutions.de

4.6

USD20.85 USD56.85

Pay in 4 interest-free payments of $5.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 20 - Sep 25

Description

CiteSpace and VOSviewer were used for bibliometric analysis, including cluster analysis, co-occurrence analysis, co-citation analysis, and burst analysis of countries/regions, institutions, journals, authors, references, and keywords

Areid N, Peltola A, Kangasniemi I, Ballo A, Narhi TO

and conduct a deeper analysis of the molecular pathways that mediate the effects of Rg1 to fully understand its role in neurodegenerative disease treatment

Cellular phagocytic activity was quantified as mean fluorescence intensity (MFI) green using a FACS Canto II flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA)